IN THIS SECTION

Taskforce data references

Quantis Reference Information

Please refer to the Disclaimer document for data source and copyright statements. This report has been provided by the Taskforce for Lung Health in response to your request for the data it contains. All website links within the disclaimer are external websites. The Taskforce for Lung Health is not responsible for the content of those websites.

Within the Taskforce for Lung Health dashboards, users can view data from the following datasets:

Hospital Episode Statistics Admitted Patient Care (HES APC – often referred to as ‘Inpatient’)
Hospital Episode Statistics Outpatient (HES OP)
Emergency Care Data Set (ECDS)
Quality and Outcomes Framework (QOF)
Smoking Prevalence in adults (from the Annual Population Survey)
Referral to Treatment (RTT) Waiting Times
English Prescribing Dataset (EPD – often referred to as GP Prescribing)
Secondary Care Medicines Data (SCMD)

This reference document provides information relating to the data in the dashboards in terms of the data sources, the diagnostic codes used, and definitions for the metrics shown. It also explains how data are suppressed where necessary to protect patient confidentiality.

Spells and Episodes

When a patient is admitted for an inpatient stay of any length (an admission), they are placed under the care of one or more consultants. Every stay of care under one consultant is called an episode, when they move to another consultant, this generates another episode. The total time spent in hospital/under the care of the physician is called a spell. Each spell can have one or more episodes.

In the Taskforce for Lung Health dashboards, costs are calculated for the entire spell of care, rather than just the first episode in the spell (the admission episode). This therefore considers the entire cost of care for a stay, including any stays where a patient is not admitted with a diagnosis but goes on to either be diagnosed or recognized as having a particular coded diagnosis in later episodes.

The cost calculation for calculating the cost of a spell is discussed in more detail in the HES Metrics section of this document below.

HES APC data

HES APC data within the Taskforce for Lung Health dashboards is for patients with the following diagnoses: all respiratory conditions; influenza; pneumonia; chronic obstructive pulmonary disease (COPD); asthma; bronchiectasis; interstitial lung disease. The corresponding ICD-10 codes, along with the description used in the dashboards, are listed below; further information on these codes can be found at https://icd.who.int/browse10/2019/en.

ICD-10 Code	ICD-10 Description	Dashboard Description
J00X	Acute nasopharyngitis [common cold]	J00 to J99 – All Respiratory Conditions
J010	Acute maxillary sinusitis	J00 to J99 – All Respiratory Conditions
J011	Acute frontal sinusitis	J00 to J99 – All Respiratory Conditions
J012	Acute ethmoidal sinusitis	J00 to J99 – All Respiratory Conditions
J013	Acute sphenoidal sinusitis	J00 to J99 – All Respiratory Conditions
J014	Acute pansinusitis	J00 to J99 – All Respiratory Conditions
J018	Other acute sinusitis	J00 to J99 – All Respiratory Conditions
J019	Acute sinusitis, unspecified	J00 to J99 – All Respiratory Conditions
J020	Streptococcal pharyngitis	J00 to J99 – All Respiratory Conditions
J028	Acute pharyngitis due to other specified organisms	J00 to J99 – All Respiratory Conditions
J029	Acute pharyngitis, unspecified	J00 to J99 – All Respiratory Conditions
J030	Streptococcal tonsillitis	J00 to J99 – All Respiratory Conditions
J038	Acute tonsillitis due to other specified organisms	J00 to J99 – All Respiratory Conditions
J039	Acute tonsillitis, unspecified	J00 to J99 – All Respiratory Conditions
J040	Acute laryngitis	J00 to J99 – All Respiratory Conditions
J041	Acute tracheitis	J00 to J99 – All Respiratory Conditions
J042	Acute laryngotracheitis	J00 to J99 – All Respiratory Conditions
J050	Acute obstructive laryngitis [croup]	J00 to J99 – All Respiratory Conditions
J051	Acute epiglottitis	J00 to J99 – All Respiratory Conditions
J060	Acute laryngopharyngitis	J00 to J99 – All Respiratory Conditions
J068	Other acute upper respiratory infections of multiple sites	J00 to J99 – All Respiratory Conditions
J069	Acute upper respiratory infection, unspecified	J00 to J99 – All Respiratory Conditions
J09X	Influenza due to identified zoonotic or pandemic influenza virus	J00 to J99 – All Respiratory Conditions
J100	Influenza with pneumonia, seasonal influenza virus identified	J00 to J99 – All Respiratory Conditions
J101	Influenza with other respiratory manifestations, seasonal influenza virus identified	J00 to J99 – All Respiratory Conditions
J108	Influenza with other manifestations, seasonal influenza virus identified	J00 to J99 – All Respiratory Conditions
J110	Influenza with pneumonia, virus not identified	J00 to J99 – All Respiratory Conditions
J111	Influenza with other respiratory manifestations, virus not identified	J00 to J99 – All Respiratory Conditions
J118	Influenza with other manifestations, virus not identified	J00 to J99 – All Respiratory Conditions
J120	Adenoviral pneumonia	J00 to J99 – All Respiratory Conditions
J121	Respiratory syncytial virus pneumonia	J00 to J99 – All Respiratory Conditions
J122	Parainfluenza virus pneumonia	J00 to J99 – All Respiratory Conditions
J123	Human metapneumovirus pneumonia	J00 to J99 – All Respiratory Conditions
J128	Other viral pneumonia	J00 to J99 – All Respiratory Conditions
J129	Viral pneumonia, unspecified	J00 to J99 – All Respiratory Conditions
J13X	Pneumonia due to Streptococcus pneumoniae	J00 to J99 – All Respiratory Conditions
J14X	Pneumonia due to Haemophilus influenzae	J00 to J99 – All Respiratory Conditions
J150	Pneumonia due to Klebsiella pneumoniae	J00 to J99 – All Respiratory Conditions
J151	Pneumonia due to Pseudomonas	J00 to J99 – All Respiratory Conditions
J152	Pneumonia due to staphylococcus	J00 to J99 – All Respiratory Conditions
J153	Pneumonia due to streptococcus, group B	J00 to J99 – All Respiratory Conditions
J154	Pneumonia due to other streptococci	J00 to J99 – All Respiratory Conditions
J155	Pneumonia due to Escherichia coli	J00 to J99 – All Respiratory Conditions
J156	Pneumonia due to other Gram-negative bacteria	J00 to J99 – All Respiratory Conditions
J157	Pneumonia due to Mycoplasma pneumoniae	J00 to J99 – All Respiratory Conditions
J158	Other bacterial pneumonia	J00 to J99 – All Respiratory Conditions
J159	Bacterial pneumonia, unspecified	J00 to J99 – All Respiratory Conditions
J160	Chlamydial pneumonia	J00 to J99 – All Respiratory Conditions
J168	Pneumonia due to other specified infectious organisms	J00 to J99 – All Respiratory Conditions
J170	Pneumonia in bacterial diseases classified elsewhere	J00 to J99 – All Respiratory Conditions
J171	Pneumonia in viral diseases classified elsewhere	J00 to J99 – All Respiratory Conditions
J172	Pneumonia in mycoses	J00 to J99 – All Respiratory Conditions
J173	Pneumonia in parasitic diseases	J00 to J99 – All Respiratory Conditions
J178	Pneumonia in other diseases classified elsewhere	J00 to J99 – All Respiratory Conditions
J180	Bronchopneumonia, unspecified	J00 to J99 – All Respiratory Conditions
J181	Lobar pneumonia, unspecified	J00 to J99 – All Respiratory Conditions
J182	Hypostatic pneumonia, unspecified	J00 to J99 – All Respiratory Conditions
J188	Other pneumonia, organism unspecified	J00 to J99 – All Respiratory Conditions
J189	Pneumonia, unspecified	J00 to J99 – All Respiratory Conditions
J200	Acute bronchitis due to Mycoplasma pneumoniae	J00 to J99 – All Respiratory Conditions
J201	Acute bronchitis due to Haemophilus influenzae	J00 to J99 – All Respiratory Conditions
J202	Acute bronchitis due to streptococcus	J00 to J99 – All Respiratory Conditions
J203	Acute bronchitis due to coxsackievirus	J00 to J99 – All Respiratory Conditions
J204	Acute bronchitis due to parainfluenza virus	J00 to J99 – All Respiratory Conditions
J205	Acute bronchitis due to respiratory syncytial virus	J00 to J99 – All Respiratory Conditions
J206	Acute bronchitis due to rhinovirus	J00 to J99 – All Respiratory Conditions
J207	Acute bronchitis due to echovirus	J00 to J99 – All Respiratory Conditions
J208	Acute bronchitis due to other specified organisms	J00 to J99 – All Respiratory Conditions
J209	Acute bronchitis, unspecified	J00 to J99 – All Respiratory Conditions
J210	Acute bronchiolitis due to respiratory syncytial virus	J00 to J99 – All Respiratory Conditions
J211	Acute bronchiolitis due to human metapneumovirus	J00 to J99 – All Respiratory Conditions
J218	Acute bronchiolitis due to other specified organisms	J00 to J99 – All Respiratory Conditions
J219	Acute bronchiolitis, unspecified	J00 to J99 – All Respiratory Conditions
J22X	Unspecified acute lower respiratory infection	J00 to J99 – All Respiratory Conditions
J300	Vasomotor rhinitis	J00 to J99 – All Respiratory Conditions
J301	Allergic rhinitis due to pollen	J00 to J99 – All Respiratory Conditions
J302	Other seasonal allergic rhinitis	J00 to J99 – All Respiratory Conditions
J303	Other allergic rhinitis	J00 to J99 – All Respiratory Conditions
J304	Allergic rhinitis, unspecified	J00 to J99 – All Respiratory Conditions
J310	Chronic rhinitis	J00 to J99 – All Respiratory Conditions
J311	Chronic nasopharyngitis	J00 to J99 – All Respiratory Conditions
J312	Chronic pharyngitis	J00 to J99 – All Respiratory Conditions
J320	Chronic maxillary sinusitis	J00 to J99 – All Respiratory Conditions
J321	Chronic frontal sinusitis	J00 to J99 – All Respiratory Conditions
J322	Chronic ethmoidal sinusitis	J00 to J99 – All Respiratory Conditions
J323	Chronic sphenoidal sinusitis	J00 to J99 – All Respiratory Conditions
J324	Chronic pansinusitis	J00 to J99 – All Respiratory Conditions
J328	Other chronic sinusitis	J00 to J99 – All Respiratory Conditions
J329	Chronic sinusitis, unspecified	J00 to J99 – All Respiratory Conditions
J330	Polyp of nasal cavity	J00 to J99 – All Respiratory Conditions
J331	Polypoid sinus degeneration	J00 to J99 – All Respiratory Conditions
J338	Other polyp of sinus	J00 to J99 – All Respiratory Conditions
J339	Nasal polyp, unspecified	J00 to J99 – All Respiratory Conditions
J340	Abscess, furuncle and carbuncle of nose	J00 to J99 – All Respiratory Conditions
J341	Cyst and mucocele of nose and nasal sinus	J00 to J99 – All Respiratory Conditions
J342	Deviated nasal septum	J00 to J99 – All Respiratory Conditions
J343	Hypertrophy of nasal turbinates	J00 to J99 – All Respiratory Conditions
J348	Other specified disorders of nose and nasal sinuses	J00 to J99 – All Respiratory Conditions
J350	Chronic tonsillitis	J00 to J99 – All Respiratory Conditions
J351	Hypertrophy of tonsils	J00 to J99 – All Respiratory Conditions
J352	Hypertrophy of adenoids	J00 to J99 – All Respiratory Conditions
J353	Hypertrophy of tonsils with hypertrophy of adenoids	J00 to J99 – All Respiratory Conditions
J358	Other chronic diseases of tonsils and adenoids	J00 to J99 – All Respiratory Conditions
J359	Chronic disease of tonsils and adenoids, unspecified	J00 to J99 – All Respiratory Conditions
J36X	Peritonsillar abscess	J00 to J99 – All Respiratory Conditions
J370	Chronic laryngitis	J00 to J99 – All Respiratory Conditions
J371	Chronic laryngotracheitis	J00 to J99 – All Respiratory Conditions
J380	Paralysis of vocal cords and larynx	J00 to J99 – All Respiratory Conditions
J381	Polyp of vocal cord and larynx	J00 to J99 – All Respiratory Conditions
J382	Nodules of vocal cords	J00 to J99 – All Respiratory Conditions
J383	Other diseases of vocal cords	J00 to J99 – All Respiratory Conditions
J384	Oedema of larynx	J00 to J99 – All Respiratory Conditions
J385	Laryngeal spasm	J00 to J99 – All Respiratory Conditions
J386	Stenosis of larynx	J00 to J99 – All Respiratory Conditions
J387	Other diseases of larynx	J00 to J99 – All Respiratory Conditions
J390	Retropharyngeal and parapharyngeal abscess	J00 to J99 – All Respiratory Conditions
J391	Other abscess of pharynx	J00 to J99 – All Respiratory Conditions
J392	Other diseases of pharynx	J00 to J99 – All Respiratory Conditions
J393	Upper respiratory tract hypersensitivity reaction, site unspecified	J00 to J99 – All Respiratory Conditions
J398	Other specified diseases of upper respiratory tract	J00 to J99 – All Respiratory Conditions
J399	Disease of upper respiratory tract, unspecified	J00 to J99 – All Respiratory Conditions
J40X	Bronchitis, not specified as acute or chronic	J00 to J99 – All Respiratory Conditions
J410	Simple chronic bronchitis	J00 to J99 – All Respiratory Conditions
J411	Mucopurulent chronic bronchitis	J00 to J99 – All Respiratory Conditions
J418	Mixed simple and mucopurulent chronic bronchitis	J00 to J99 – All Respiratory Conditions
J42X	Unspecified chronic bronchitis	J00 to J99 – All Respiratory Conditions
J430	MacLeod syndrome	J00 to J99 – All Respiratory Conditions
J431	Panlobular emphysema	J00 to J99 – All Respiratory Conditions
J432	Centrilobular emphysema	J00 to J99 – All Respiratory Conditions
J438	Other emphysema	J00 to J99 – All Respiratory Conditions
J439	Emphysema, unspecified	J00 to J99 – All Respiratory Conditions
J440	Chronic obstructive pulmonary disease with acute lower respiratory infection	J00 to J99 – All Respiratory Conditions
J441	Chronic obstructive pulmonary disease with acute exacerbation, unspecified	J00 to J99 – All Respiratory Conditions
J448	Other specified chronic obstructive pulmonary disease	J00 to J99 – All Respiratory Conditions
J449	Chronic obstructive pulmonary disease, unspecified	J00 to J99 – All Respiratory Conditions
J450	Predominantly allergic asthma	J00 to J99 – All Respiratory Conditions
J451	Nonallergic asthma	J00 to J99 – All Respiratory Conditions
J458	Mixed asthma	J00 to J99 – All Respiratory Conditions
J459	Asthma, unspecified	J00 to J99 – All Respiratory Conditions
J46X	Status asthmaticus	J00 to J99 – All Respiratory Conditions
J47X	Bronchiectasis	J00 to J99 – All Respiratory Conditions
J60X	Coalworker pneumoconiosis	J00 to J99 – All Respiratory Conditions
J61X	Pneumoconiosis due to asbestos and other mineral fibres	J00 to J99 – All Respiratory Conditions
J620	Pneumoconiosis due to talc dust	J00 to J99 – All Respiratory Conditions
J628	Pneumoconiosis due to other dust containing silica	J00 to J99 – All Respiratory Conditions
J630	Aluminosis (of lung)	J00 to J99 – All Respiratory Conditions
J631	Bauxite fibrosis (of lung)	J00 to J99 – All Respiratory Conditions
J632	Berylliosis	J00 to J99 – All Respiratory Conditions
J633	Graphite fibrosis (of lung)	J00 to J99 – All Respiratory Conditions
J634	Siderosis	J00 to J99 – All Respiratory Conditions
J635	Stannosis	J00 to J99 – All Respiratory Conditions
J638	Pneumoconiosis due to other specified inorganic dusts	J00 to J99 – All Respiratory Conditions
J64X	Unspecified pneumoconiosis	J00 to J99 – All Respiratory Conditions
J65X	Pneumoconiosis associated with tuberculosis	J00 to J99 – All Respiratory Conditions
J660	Byssinosis	J00 to J99 – All Respiratory Conditions
J661	Flax-dresser disease	J00 to J99 – All Respiratory Conditions
J662	Cannabinosis	J00 to J99 – All Respiratory Conditions
J668	Airway disease due to other specific organic dusts	J00 to J99 – All Respiratory Conditions
J670	Farmer lung	J00 to J99 – All Respiratory Conditions
J671	Bagassosis	J00 to J99 – All Respiratory Conditions
J672	Bird fancier lung	J00 to J99 – All Respiratory Conditions
J673	Suberosis	J00 to J99 – All Respiratory Conditions
J674	Maltworker lung	J00 to J99 – All Respiratory Conditions
J675	Mushroom-worker lung	J00 to J99 – All Respiratory Conditions
J676	Maple-bark-stripper lung	J00 to J99 – All Respiratory Conditions
J677	Air-conditioner and humidifier lung	J00 to J99 – All Respiratory Conditions
J678	Hypersensitivity pneumonitis due to other organic dusts	J00 to J99 – All Respiratory Conditions
J679	Hypersensitivity pneumonitis due to unspecified organic dust	J00 to J99 – All Respiratory Conditions
J680	Bronchitis and pneumonitis due to chemicals, gases, fumes and vapours	J00 to J99 – All Respiratory Conditions
J681	Pulmonary oedema due to chemicals, gases, fumes and vapours	J00 to J99 – All Respiratory Conditions
J682	Upper respiratory inflammation due to chemicals, gases, fumes and vapours, not elsewhere classified	J00 to J99 – All Respiratory Conditions
J683	Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapours	J00 to J99 – All Respiratory Conditions
J684	Chronic respiratory conditions due to chemicals, gases, fumes and vapours	J00 to J99 – All Respiratory Conditions
J688	Other respiratory conditions due to chemicals, gases, fumes and vapours	J00 to J99 – All Respiratory Conditions
J689	Unspecified respiratory condition due to chemicals, gases, fumes and vapours	J00 to J99 – All Respiratory Conditions
J690	Pneumonitis due to food and vomit	J00 to J99 – All Respiratory Conditions
J691	Pneumonitis due to oils and essences	J00 to J99 – All Respiratory Conditions
J698	Pneumonitis due to other solids and liquids	J00 to J99 – All Respiratory Conditions
J700	Acute pulmonary manifestations due to radiation	J00 to J99 – All Respiratory Conditions
J701	Chronic and other pulmonary manifestations due to radiation	J00 to J99 – All Respiratory Conditions
J702	Acute drug-induced interstitial lung disorders	J00 to J99 – All Respiratory Conditions
J703	Chronic drug-induced interstitial lung disorders	J00 to J99 – All Respiratory Conditions
J704	Drug-induced interstitial lung disorders, unspecified	J00 to J99 – All Respiratory Conditions
J708	Respiratory conditions due to other specified external agents	J00 to J99 – All Respiratory Conditions
J709	Respiratory conditions due to unspecified external agent	J00 to J99 – All Respiratory Conditions
J80X	Adult respiratory distress syndrome	J00 to J99 – All Respiratory Conditions
J81X	Pulmonary oedema	J00 to J99 – All Respiratory Conditions
J82X	Pulmonary eosinophilia, not elsewhere classified	J00 to J99 – All Respiratory Conditions
J840	Alveolar and parietoalveolar conditions	J00 to J99 – All Respiratory Conditions
J841	Other interstitial pulmonary diseases with fibrosis	J00 to J99 – All Respiratory Conditions
J848	Other specified interstitial pulmonary diseases	J00 to J99 – All Respiratory Conditions
J849	Interstitial pulmonary disease, unspecified	J00 to J99 – All Respiratory Conditions
J850	Gangrene and necrosis of lung	J00 to J99 – All Respiratory Conditions
J851	Abscess of lung with pneumonia	J00 to J99 – All Respiratory Conditions
J852	Abscess of lung without pneumonia	J00 to J99 – All Respiratory Conditions
J853	Abscess of mediastinum	J00 to J99 – All Respiratory Conditions
J860	Pyothorax with fistula	J00 to J99 – All Respiratory Conditions
J869	Pyothorax without fistula	J00 to J99 – All Respiratory Conditions
J90X	Pleural effusion, not elsewhere classified	J00 to J99 – All Respiratory Conditions
J91X	Pleural effusion in conditions classified elsewhere	J00 to J99 – All Respiratory Conditions
J920	Pleural plaque with presence of asbestos	J00 to J99 – All Respiratory Conditions
J929	Pleural plaque without asbestos	J00 to J99 – All Respiratory Conditions
J930	Spontaneous tension pneumothorax	J00 to J99 – All Respiratory Conditions
J931	Other spontaneous pneumothorax	J00 to J99 – All Respiratory Conditions
J938	Other pneumothorax	J00 to J99 – All Respiratory Conditions
J939	Pneumothorax, unspecified	J00 to J99 – All Respiratory Conditions
J940	Chylous effusion	J00 to J99 – All Respiratory Conditions
J941	Fibrothorax	J00 to J99 – All Respiratory Conditions
J942	Haemothorax	J00 to J99 – All Respiratory Conditions
J948	Other specified pleural conditions	J00 to J99 – All Respiratory Conditions
J949	Pleural condition, unspecified	J00 to J99 – All Respiratory Conditions
J950	Tracheostomy malfunction	J00 to J99 – All Respiratory Conditions
J951	Acute pulmonary insufficiency following thoracic surgery	J00 to J99 – All Respiratory Conditions
J952	Acute pulmonary insufficiency following nonthoracic surgery	J00 to J99 – All Respiratory Conditions
J953	Chronic pulmonary insufficiency following surgery	J00 to J99 – All Respiratory Conditions
J954	Mendelson syndrome	J00 to J99 – All Respiratory Conditions
J955	Postprocedural subglottic stenosis	J00 to J99 – All Respiratory Conditions
J958	Other postprocedural respiratory disorders	J00 to J99 – All Respiratory Conditions
J959	Postprocedural respiratory disorder, unspecified	J00 to J99 – All Respiratory Conditions
J960	Acute respiratory failure	J00 to J99 – All Respiratory Conditions
J961	Chronic respiratory failure	J00 to J99 – All Respiratory Conditions
J969	Respiratory failure, unspecified	J00 to J99 – All Respiratory Conditions
J980	Diseases of bronchus, not elsewhere classified	J00 to J99 – All Respiratory Conditions
J981	Pulmonary collapse	J00 to J99 – All Respiratory Conditions
J982	Interstitial emphysema	J00 to J99 – All Respiratory Conditions
J983	Compensatory emphysema	J00 to J99 – All Respiratory Conditions
J984	Other disorders of lung	J00 to J99 – All Respiratory Conditions
J985	Diseases of mediastinum, not elsewhere classified	J00 to J99 – All Respiratory Conditions
J986	Disorders of diaphragm	J00 to J99 – All Respiratory Conditions
J988	Other specified respiratory disorders	J00 to J99 – All Respiratory Conditions
J989	Respiratory disorder, unspecified	J00 to J99 – All Respiratory Conditions
J990	Rheumatoid lung disease	J00 to J99 – All Respiratory Conditions
J991	Respiratory disorders in other diffuse connective tissue disorders	J00 to J99 – All Respiratory Conditions
J998	Respiratory disorders in other diseases classified elsewhere	J00 to J99 – All Respiratory Conditions
J09X	Influenza due to identified zoonotic or pandemic influenza virus	J09 to J11 – Influenza
J100	Influenza with pneumonia, seasonal influenza virus identified	J09 to J11 – Influenza
J101	Influenza with other respiratory manifestations, seasonal influenza virus identified	J09 to J11 – Influenza
J108	Influenza with other manifestations, seasonal influenza virus identified	J09 to J11 – Influenza
J110	Influenza with pneumonia, virus not identified	J09 to J11 – Influenza
J111	Influenza with other respiratory manifestations, virus not identified	J09 to J11 – Influenza
J118	Influenza with other manifestations, virus not identified	J09 to J11 – Influenza
J120	Adenoviral pneumonia	J12 to J18 – Pneumonia
J121	Respiratory syncytial virus pneumonia	J12 to J18 – Pneumonia
J122	Parainfluenza virus pneumonia	J12 to J18 – Pneumonia
J123	Human metapneumovirus pneumonia	J12 to J18 – Pneumonia
J128	Other viral pneumonia	J12 to J18 – Pneumonia
J129	Viral pneumonia, unspecified	J12 to J18 – Pneumonia
J13X	Pneumonia due to Streptococcus pneumoniae	J12 to J18 – Pneumonia
J14X	Pneumonia due to Haemophilus influenzae	J12 to J18 – Pneumonia
J150	Pneumonia due to Klebsiella pneumoniae	J12 to J18 – Pneumonia
J151	Pneumonia due to Pseudomonas	J12 to J18 – Pneumonia
J152	Pneumonia due to staphylococcus	J12 to J18 – Pneumonia
J153	Pneumonia due to streptococcus, group B	J12 to J18 – Pneumonia
J154	Pneumonia due to other streptococci	J12 to J18 – Pneumonia
J155	Pneumonia due to Escherichia coli	J12 to J18 – Pneumonia
J156	Pneumonia due to other Gram-negative bacteria	J12 to J18 – Pneumonia
J157	Pneumonia due to Mycoplasma pneumoniae	J12 to J18 – Pneumonia
J158	Other bacterial pneumonia	J12 to J18 – Pneumonia
J159	Bacterial pneumonia, unspecified	J12 to J18 – Pneumonia
J160	Chlamydial pneumonia	J12 to J18 – Pneumonia
J168	Pneumonia due to other specified infectious organisms	J12 to J18 – Pneumonia
J170	Pneumonia in bacterial diseases classified elsewhere	J12 to J18 – Pneumonia
J171	Pneumonia in viral diseases classified elsewhere	J12 to J18 – Pneumonia
J172	Pneumonia in mycoses	J12 to J18 – Pneumonia
J173	Pneumonia in parasitic diseases	J12 to J18 – Pneumonia
J178	Pneumonia in other diseases classified elsewhere	J12 to J18 – Pneumonia
J180	Bronchopneumonia, unspecified	J12 to J18 – Pneumonia
J181	Lobar pneumonia, unspecified	J12 to J18 – Pneumonia
J182	Hypostatic pneumonia, unspecified	J12 to J18 – Pneumonia
J188	Other pneumonia, organism unspecified	J12 to J18 – Pneumonia
J189	Pneumonia, unspecified	J12 to J18 – Pneumonia
J40X	Bronchitis, not specified as acute or chronic	J40 to J44 – COPD
J410	Simple chronic bronchitis	J40 to J44 – COPD
J411	Mucopurulent chronic bronchitis	J40 to J44 – COPD
J418	Mixed simple and mucopurulent chronic bronchitis	J40 to J44 – COPD
J42X	Unspecified chronic bronchitis	J40 to J44 – COPD
J430	MacLeod syndrome	J40 to J44 – COPD
J431	Panlobular emphysema	J40 to J44 – COPD
J432	Centrilobular emphysema	J40 to J44 – COPD
J438	Other emphysema	J40 to J44 – COPD
J439	Emphysema, unspecified	J40 to J44 – COPD
J440	Chronic obstructive pulmonary disease with acute lower respiratory infection	J40 to J44 – COPD
J441	Chronic obstructive pulmonary disease with acute exacerbation, unspecified	J40 to J44 – COPD
J448	Other specified chronic obstructive pulmonary disease	J40 to J44 – COPD
J449	Chronic obstructive pulmonary disease, unspecified	J40 to J44 – COPD
J450	Predominantly allergic asthma	J45 to J46 – Asthma
J451	Nonallergic asthma	J45 to J46 – Asthma
J458	Mixed asthma	J45 to J46 – Asthma
J459	Asthma, unspecified	J45 to J46 – Asthma
J46X	Status asthmaticus	J45 to J46 – Asthma
J47X	Bronchiectasis	J47 – Bronchiectasis
J840	Alveolar and parietoalveolar conditions	J84 – Interstitial Lung Disease
J841	Other interstitial pulmonary diseases with fibrosis	J84 – Interstitial Lung Disease
J848	Other specified interstitial pulmonary diseases	J84 – Interstitial Lung Disease
J849	Interstitial pulmonary disease, unspecified	J84 – Interstitial Lung Disease

HES OP data

HES OP data within the Taskforce for Lung Health dashboards shows hospital appointments within the consultant specialty of Respiratory Medicine.

HES APC and OP Metrics

There are a variety of HES metrics that can be analysed in the Taskforce for Lung Health dashboards. Below is an outline of each, along with relevant definitions.

Admissions – The number of spells of care containing the selected filter options. A spell is the total continuous stay of a patient using a hospital bed, after admission to hospital. A spell can be made up of multiple episodes, including critical care episodes. An episode is the time a patient spends under the continuous care of a consultant/health care professional.

Patients – The number of distinct patients having the selected filter options. A patient can come into hospital multiple times for the same diagnosis, but when looking at patient count you are looking at the distinct number of patients for the selected filters.

Bed Days – The total duration of all spells of care, in days. It is the duration between the admission date and the final episode discharge date.

Cost – The cost of the spell of care, this is calculated using the national tariff cost for the spell, as determined by the spell HRG attached to the record. It is not the cost of the procedure or diagnosis, but the reimbursement given from the CCG to the provider. Market forces factoring, and extra payments such as excess bed days costs have been applied as set out by NHSE. The cost of the spell may not include device costs, e.g. high cost devices. Further information on the national tariff can be found here: https://www.england.nhs.uk/pay-syst/national-tariff/

Costs are calculated as follows:

Cost per Patient – Calculated by dividing the cost (as above) of the spell by the number of patients having the selected filter options. Reported in pounds.

Mean Length of Stay (MLOS) – The average spell length, in days, for the selected filter options. MLOS is calculated by dividing the number of bed days by the number of spells.

Spells per Patient – Calculated as the number of distinct spells divided by the number of distinct patients for the selected filters.

Appointments – The number of outpatient appointments for the selected filter options.

Average RTT Wait – The average Referral to Treatment (RTT) wait duration for the selected filter options. Reported in days.

Further information can be found here: https://datadictionary.nhs.uk/about/about.html

Spells: https://datadictionary.nhs.uk/nhs_business_definitions/hospital_provider_spell.html

Finished Consultant Episodes (FCEs): https://datadictionary.nhs.uk/nhs_business_definitions/consultant_episode__hospital_provider_.html

Definitions

There are a variety of HES-related terms used within the Taskforce for Lung Health dashboards, which are outlined below.

Elective – When admission to hospital for treatment is from the waiting list.

Non-Elective – When admission is unpredictable and at short notice because of clinical need.

30-day re-admission – Non-Elective admission within 30 days of a previous admission.

60-day re-admission – Non-Elective admission within 60 days of a previous admission.

Teleconsultation – Telehealth appointment.

Non-Teleconsultation – Non-Telehealth appointment.

All – All hospital activity regardless of admission type (e.g. Elective or Non-Elective) or appointment type (e.g. Tele or Non-Tele).

ECDS data

ECDS data within the Taskforce for Lung Health dashboards is for attendances where the following conditions are recorded as a diagnosis or a comorbidity: all respiratory conditions; influenza; pneumonia; chronic obstructive pulmonary disease (COPD); asthma; bronchiectasis; interstitial lung disease. The ECDS uses SNOMED codes for identifying diagnosis/comorbidity; the corresponding SNOMED codes, along with the description used in the dashboards, are listed below.

SNOMED Code	SNOMED Description	Dashboard Description
195951007	Acute exacerbation of chronic obstructive airways disease	J00 to J99 – All Respiratory Conditions
22607003	Asbestosis	J00 to J99 – All Respiratory Conditions
422588002	Aspiration pneumonia	J00 to J99 – All Respiratory Conditions
195967001	Asthma	J00 to J99 – All Respiratory Conditions
12295008	Bronchiectasis	J00 to J99 – All Respiratory Conditions
13645005	COPD – Chronic obstructive pulmonary disease	J00 to J99 – All Respiratory Conditions
58554001	Empyema of pleura	J00 to J99 – All Respiratory Conditions
80384002	Epiglottitis	J00 to J99 – All Respiratory Conditions
37471005	Extrinsic allergic alveolitis	J00 to J99 – All Respiratory Conditions
709109004	Hypercapnic respiratory failure	J00 to J99 – All Respiratory Conditions
6142004	Influenza	J00 to J99 – All Respiratory Conditions
233703007	Interstitial lung disease	J00 to J99 – All Respiratory Conditions
278516003	Lobar pneumonia	J00 to J99 – All Respiratory Conditions
50417007	Lower respiratory tract infection	J00 to J99 – All Respiratory Conditions
60046008	Pleural effusion	J00 to J99 – All Respiratory Conditions
233658003	Pleural plaque	J00 to J99 – All Respiratory Conditions
40122008	Pneumoconiosis	J00 to J99 – All Respiratory Conditions
233604007	Pneumonia	J00 to J99 – All Respiratory Conditions
205237003	Pneumonitis	J00 to J99 – All Respiratory Conditions
233765002	Respiratory failure without hypercapnia	J00 to J99 – All Respiratory Conditions
80423007	Spontaneous pneumothorax	J00 to J99 – All Respiratory Conditions
62994001	Tracheitis	J00 to J99 – All Respiratory Conditions
54150009	Upper respiratory infection	J00 to J99 – All Respiratory Conditions
6142004	Influenza	J09 to J11 – Influenza
278516003	Lobar pneumonia	J12 to J18 – Pneumonia
233604007	Pneumonia	J12 to J18 – Pneumonia
195951007	Acute exacerbation of chronic obstructive airways disease	J40 to J44 – COPD
13645005	COPD – Chronic obstructive pulmonary disease	J40 to J44 – COPD
195967001	Asthma	J45 to J46 – Asthma
12295008	Bronchiectasis	J47 – Bronchiectasis
233703007	Interstitial lung disease	J84 – Interstitial Lung Disease

ECDS Metrics

There are a variety of ECDS metrics that can be viewed in the dashboards. Below is an outline of each, along with the corresponding definition.

Attendances – The number of ECDS attendances for the selected filter options.

Attendances >4 hours – The number of ECDS attendances where the reported departure time since arrival is greater than 4 hours.

% Attendances >4 hours – The number of ECDS attendances >4 hours expressed as a percentage of attendances.

% Total Attendances – The number of attendances for the selected filter options expressed as a percentage of all ECDS attendances.

Patients – The number of distinct patients for the selected filter options. A patient may have multiple attendances with the same diagnosis/comorbidity recorded, but when looking at a patient count you are looking at the distinct number of patients.

Attendances per Patient – Calculated by dividing the number of attendances by the number of distinct patients for the selected filter options.

Cost – The cost of the attendance, as recorded in the ECDS, for the selected filter options. Reported in pounds.

Admissions – The number of attendances where the discharge destination is recorded as an admission.

% Admissions – The number of admissions expressed as a percentage of attendances.

HES and ECDS Suppression

To protect the privacy and confidentiality of individuals, HSJ Information have applied suppression to potentially identifiable figures (e.g. patient numbers, spell/appointment counts). In the HES and ECDS data, ‘*’ or ‘-1’ represents a figure between 1 and 7; all other potentially identifiable figures have been rounded to the nearest 5.

Calculations (e.g. Cost per Patient) have been produced from the original, unrounded values. Secondary suppression is applied to calculations where an original value used in the calculation is suppressed, e.g. if the number of patients is suppressed, the cost per patient will also be suppressed. Secondary suppressed values are also represented by ‘*’ or ‘-1’.

Please note that row/column totals will be calculated and then rounded, which means that the total of rounded values may differ from the rounded total, as in the following example:

A white paper with black text

Description automatically generated

After suppression has taken place this table will become:

A white rectangular box with black text

Description automatically generated with medium confidence

On no account should an attempt be made to decipher the process of creating anonymised data items.

Quality and Outcomes Framework (QOF) data

The QOF data within the Taskforce for Lung Health dashboards is for the following indicators:

QOF Indicator Code	QOF Indicator Description
AST005	The contractor establishes and maintains a register of patients with asthma aged 6 years or over, excluding patients with asthma who have been prescribed no asthma related drugs in the preceding 12 months.
AST006	The percentage of patients with a diagnosis of asthma on or after 1 April 2021 with either: 1. A record of spirometry and one other objective test (FeNO or reversibility or variability) between 3 months before and 6 months after diagnosis; or 2. If newly registered in the preceding 12 months with a diagnosis of asthma recorded on or after 1 April 2021 but no record of objective tests being performed at the date of registration, with a record of spirometry and one other objective test (FeNO or reversibility or variability) recorded within 6 months of registration.
AST007	The percentage of patients with asthma on the register, who have had an asthma review in the preceding 12 months that includes an assessment of asthma control using a validated asthma control questionnaire, a recording of the number of exacerbations, an assessment of inhaler technique and a written personalised action plan.
AST008	The percentage of patients with asthma on the register aged 19 or under, in whom there is a record of either personal smoking status or exposure to second-hand smoke in the preceding 12 months.
COPD009	The contractor establishes and maintains a register of: 1. Patients with a clinical diagnosis of COPD before 1 April 2021 and 2. Patients with a clinical diagnosis of COPD on or after 1 April 2021 whose diagnosis has been confirmed by a quality assured post bronchodilator spirometry FEV₁/FVC ratio below 0.7 between 3 months before or 6 months after diagnosis (or if newly registered in the preceding 12 months a record of an FEV₁/FVC ratio below 0.7 recorded within 6 months of registration); and 3. Patients with a clinical diagnosis of COPD on or after 1 April 2021 who are unable to undertake spirometry.
COPD008	The percentage of patients with COPD and Medical Research Council (MRC) dyspnoea scale ≥3 at any time in the preceding 12 months, with a subsequent record of an offer of referral to a pulmonary rehabilitation programme (excluding those who have previously attended a pulmonary rehabilitation programme).
COPD010	The percentage of patients with COPD on the register, who have had a review in the preceding 12 months, including a record of the number of exacerbations and an assessment of breathlessness using the Medical Research Council dyspnoea scale.
SMOK002	The percentage of patients with any or any combination of the following conditions: CHD, PAD, stroke or TIA, hypertension, diabetes, COPD, CKD, asthma, schizophrenia, bipolar affective disorder or other psychoses whose notes record smoking status in the preceding 12 months.
SMOK004	The percentage of patients aged 15 or over who are recorded as current smokers who have a record of an offer of support and treatment within the preceding 24 months.
SMOK005	The percentage of patients with any or any combination of the following conditions: CHD, PAD, stroke or TIA, hypertension, diabetes, COPD, CKD, asthma, schizophrenia, bipolar affective disorder or other psychoses who are recorded as current smokers who have a record of an offer of support and treatment within the preceding 12 months.

QOF indicator descriptions are taken from the 2022/23 QOF guidance, available at: https://www.england.nhs.uk/publication/update-on-quality-outcomes-framework-changes-for-2022-23/

QOF Indicator denominators, exclusions and personalised care adjustments (PCAs)

Denominators – the number of patients from the appropriate disease register who are counted for QOF achievement against a specific QOF indicator

Numerators – the number of those in the denominator who meet the specific indicator success criteria

Exclusions – patients who are on the disease register but not included in the indicator denominator for definitional reasons

PCAs – relate to patients who are on the disease register and would ordinarily be included in the indicator denominator, however they are omitted from the denominator because they meet at least one of the specified PCA criteria

The normal relationship between registers, denominators, exclusions and PCAs is:

Achievement Threshold Range – the lower and upper achievement thresholds that need to be met to earn QOF points for a particular indicator.

QOF Metrics

Underlying achievement (%) – presents the indicator numerator as a percentage of the denominator. Calculated as:

(Numerator / Denominator) *100

Patients receiving the intervention (%) – gives a more accurate indication of the rate of provision of interventions as the denominator includes all patients to whom the indicator applies. Calculated as:

(Numerator / (Denominator + PCAs)) *100

PCA rate (%) – presents indicator PCAs as a percentage of all patients to whom the indicator applies. Calculated as:

(PCAs / (PCAs + Denominator)) *100

Prevalence (%) – patients on the QOF disease register for a specific indicator as a percentage of the QOF patient register. Calculated as:

(Number of patients on QOF disease register / Number of patients on QOF patient register) *100

Absolute prevalence – the number of patients on the QOF disease register for a specific indicator

Prevalence per 100,000 – presents the number of patients on the QOF disease register normalised per 100,000 population. Calculated as:

(Number of patients on QOF disease register / Number of patients on QOF patient register) * 100,000

Smoking Prevalence in adults data

Data on smoking prevalence in adults is sourced from the Office for Health Improvement & Disparities (https://fingertips.phe.org.uk/profile/tobacco-control/data#page/9/gid/1938132885/pat/159/par/K02000001/ati/15/are/E92000001/iid/92443/age/168/sex/4/cat/-1/ctp/-1/yrr/1/cid/4/tbm/1).

Referral to Treatment (RTT) Waiting Times data

Data on consultant-led Referral to Treatment (RTT) waiting times is sourced from NHS England (https://www.england.nhs.uk/statistics/statistical-work-areas/rtt-waiting-times/).

English Prescribing Dataset (EPD)

The EPD is sourced from the NHS Business Services Authority (https://opendata.nhsbsa.net/dataset/english-prescribing-data-epd). GP Prescribing data within the Taskforce for Lung Health dashboards is for all medicines within the respiratory system chapter of the British National Formulary (BNF), which includes the following types of medicine:

Antifibrotics
Antihistamines, hyposensitisation and allergic emergencies
Aromatic inhalations
Bronchodilators
Corticosteroids (respiratory)
Cough preparations
Cromoglycate, leukotriene and phosphodiesterase type-4 inhibitors
Mucolytics
Respiratory stimulants and pulmonary surfactants
Systemic nasal decongestants

Secondary Care Medicines Data (SCMD)

SCMD with indicative price is sourced from the NHS Business Services Authority (https://opendata.nhsbsa.net/dataset/secondary-care-medicines-data-indicative-price). SCMD data within the Taskforce for Lung Health dashboards is for the following innovative biologics:

SNOMED Code	Product Name	ml Conversion
37854611000001108	Benralizumab 30mg/1ml solution for injection pre-filled disposable devices	1
35298511000001102	Benralizumab 30mg/1ml solution for injection pre-filled syringes	1
31210311000001108	Mepolizumab 100mg powder for solution for injection vials	1
37564311000001105	Mepolizumab 100mg/1ml solution for injection pre-filled disposable devices	1
37564411000001103	Mepolizumab 100mg/1ml solution for injection pre-filled syringes	1
9742911000001102	Omalizumab 150mg powder and solvent for solution for injection vials	1
18671311000001102	Omalizumab 150mg/1ml solution for injection pre-filled syringes	1
18671411000001109	Omalizumab 75mg/0.5ml solution for injection pre-filled syringes	0.5
33999611000001101	Reslizumab 100mg/10ml solution for infusion vials	10
34812511000001102	Reslizumab 25mg/2.5ml solution for infusion vials	2.5
41329711000001103	Tezepelumab 210mg/1.91ml solution for injection pre-filled syringes	1.91

Items are calculated by applying the ml conversion in the table above to the quantity reported in the SCMD:

Items = total quantity / ml conversion

Index of Multiple Deprivation (IMD)

The Index of Multiple Deprivation (IMD) is produced by combining information from the seven domains of the Indices of Deprivation: Income Deprivation; Employment Deprivation; Education, Skills and Training Deprivation; Health Deprivation and Disability; Crime; Barriers to Housing and Services; Living Environment Deprivation.

IMD is the official measure of relative deprivation for small areas (Lower-layer Super Output Areas) in England. Each area has a deprivation score and a deprivation rank (created from the score): the larger the score, the more deprived the area and the lower its rank. Deprivation quintiles are created by converting the rankings into 5 equal sections, with Quintile 1 representing the most deprived and Quintile 5 the least deprived. IMD deprivation data by Lower-layer Super Output Area (LSOA) is sourced from https://www.gov.uk/government/statistics/english-indices-of-deprivation-2019. Further information can be found at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/853811/IoD2019_FAQ_v4.pdf.

Normalisation

Normalisation can be applied to allow the fair comparison of data between organisations. Users are able to normalise the data by patient register (from the Quality Outcomes Framework dataset) per 100,000 patients. The calculation used to produce normalised figures is:

(Metric / Number of patients registered to organisation) * 100,000

Note that when selecting an ICB or PCN, the patient register will be the sum of the patient registers for the GP practices affiliated to the selected organisation. Normalisation is not available for data by Trusts as these do not have a defined population.

Links

This solution may contain links or references to products, materials or web sites that are provided by independent third parties. The availability of such third-party material does not constitute any form of recommendation, endorsement or publication of such third-party material by Taskforce for Lung Health or HSJ Information. Any complaints that you have about the third-party material or links should be taken up with the relevant third party.